# A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer

> **NCT02026921** · PHASE2 · COMPLETED · sponsor: **Nordic Society of Gynaecological Oncology - Clinical Trials Unit** · enrollment: 74 (actual)

## Conditions studied

- Ovarian Epithelial Cancer Recurrent

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT02026921
- **Lead sponsor:** Nordic Society of Gynaecological Oncology - Clinical Trials Unit
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2006-03
- **Final completion:** 2008-12
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2014-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02026921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02026921, "A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT02026921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*